Bell Investment Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Bell Investment Advisors's NVO Position: Q2 2026 in Review
Bell Investment Advisors increased its Novo Nordisk (NVO) stake by 81% in Q2 2026, buying an estimated $9.19K and bringing the position to 478 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #437.
Bell Investment Advisors first reported a position in NVO in Q3 2021 and has held it in 19 quarters since. The position peaked at $54.4K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Bell Investment Advisors held 478 shares of Novo Nordisk worth $22.9K as of Q2 2026.
- Bell Investment Advisors bought 214 Novo Nordisk shares in Q2 2026, an estimated $9.19K.
- Novo Nordisk made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #437 holding.
- Bell Investment Advisors first reported a position in Novo Nordisk in Q3 2021 and has held it in 19 quarters since.
- Bell Investment Advisors's Novo Nordisk position peaked at $54.4K in Q2 2024.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.